The reason for the refusal of the vaccine was called fears about the production of a vaccine in an American laboratory.
“Due to concerns about a drug developed at Emerging BioSolutions in Baltimore, Maryland, Health Canada will not distribute the inventory received to protect the health and safety of Canadians and Canadian women,” the Department of Health said.
It claims the vaccine was “contaminated with components of another vaccine” during manufacture, and after testing the vials, Health Canada was unable to conclude that they met Canadian standards. It also said that the delegation will inspect the Maryland plant about the incident this summer, and Canada will not accept any new vaccine shipments from that plant until then.
It is also known that the US health authorities announced the need to throw away several batches of Johnson & Johnson vaccines produced at this plant in Baltimore.
We add that in addition to the Johnson & Johnson vaccine, Pfizer-BioNTech, Moderna and AstraZeneca vaccines are used in Canada. At the same time, 64% of the population in the country has already been vaccinated with a single dose, which is one of the best indicators in the world.
– .
